Literature DB >> 22313019

Adsorption of doxorubicin on poly(methyl methacrylate)-chitosan-heparin-coated activated carbon beads.

Jianjun Miao1, Fuming Zhang, Majde Takieddin, Shaker Mousa, Robert J Linhardt.   

Abstract

Extracorporeal filter cartridges, filled with an activated carbon bead (ACB) adsorbent, have been used for removal of overdosed cancer drugs from the blood. Coatings on adsorbent matrices, poly(methyl methacrylate) (PMMA)/activated carbon bead and PMMA/chitosan/heparin/ACB composites, were tested to improve their biocompatibility and blood compatibility. PMMA coating on ACBs was accomplished in a straightforward manner using a PMMA solution in ethyl acetate. A one-step hybrid coating of ACBs with PMMA-anticoagulant heparin required the use of acetone and water co-solvents. Multilayer coatings with three components, PMMA, chitosan, and heparin, involved three steps: PMMA was first coated on ACBs; chitosan was then coated on the PMMA-coated surface; and finally, heparin was covalently attached to the chitosan coating. Surface morphologies were studied by scanning electron microscopy. X-ray photoelectron spectroscopy confirmed the -SO(3)(-) group. Adsorption, of a chemotherapy drug (doxorubicin) from both water and phosphate-buffered saline, by the coated ACBs was examined. The adsorption isotherm curves were fitted using the Freundlich model. The current adsorption system might find potential applications in the removal of high-dose regional chemotherapy drugs while maintaining high efficiency, biocompatibility, and blood compatibility.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22313019      PMCID: PMC3309418          DOI: 10.1021/la3000137

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  17 in total

1.  Percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma.

Authors:  Takeshi Maruo; Satoru Motoyama; Shinya Hamana; Shigeki Yoshida; Noriyuki Ohara; Mineo Yamasaki; Yonson Ku
Journal:  Surg Oncol Clin N Am       Date:  2008-10       Impact factor: 3.495

2.  Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation.

Authors:  M J Wissink; R Beernink; J S Pieper; A A Poot; G H Engbers; T Beugeling; W G van Aken; J Feijen
Journal:  Biomaterials       Date:  2001-01       Impact factor: 12.479

3.  Effect of sodium thiosulfate on cisplatin removal with complete hepatic venous isolation and extracorporeal charcoal hemoperfusion: a pharmacokinetic evaluation.

Authors:  N Kusunoki; Y Ku; M Tominaga; T Iwasaki; T Fukumoto; S Muramatsu; T Sugimoto; S Tsuchida; M Takamatsu; Y Suzuki; Y Kuroda
Journal:  Ann Surg Oncol       Date:  2001-06       Impact factor: 5.344

4.  Doxorubicin-heparin complex: reduction of cardiotoxicity of doxorubicin.

Authors:  Y Mizuno; T Hara; S Tachibana; K Uragoh; K Akazawa; K Ueda
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  A validated assay for measuring doxorubicin in biological fluids and tissues in an isolated lung perfusion model: matrix effect and heparin interference strongly influence doxorubicin measurements.

Authors:  A Kümmerle; T Krueger; M Dusmet; C Vallet; Y Pan; H B Ris; Laurent A Decosterd
Journal:  J Pharm Biomed Anal       Date:  2003-10-15       Impact factor: 3.935

6.  Heparin-cellulose-charcoal composites for drug detoxification prepared using room temperature ionic liquids.

Authors:  Tae-Joon Park; Sang-Hyun Lee; Trevor J Simmons; Jeffrey G Martin; Shaker A Mousa; Elisaveta A Snezhkova; Veronika V Sarnatskaya; Vladimir G Nikolaev; Robert J Linhardt
Journal:  Chem Commun (Camb)       Date:  2008-09-02       Impact factor: 6.222

7.  In vitro biocompatibility of chitosan porous skin regenerating templates (PSRTs) using primary human skin keratinocytes.

Authors:  C K Lim; N S Yaacob; Z Ismail; A S Halim
Journal:  Toxicol In Vitro       Date:  2010-01-15       Impact factor: 3.500

Review 8.  Development of isolated hepatic perfusion for patients who have unresectable hepatic malignancies.

Authors:  Adriana Jones; H Richard Alexander
Journal:  Surg Oncol Clin N Am       Date:  2008-10       Impact factor: 3.495

Review 9.  Doxorubicin: the good, the bad and the ugly effect.

Authors:  Cristina Carvalho; Renato X Santos; Susana Cardoso; Sónia Correia; Paulo J Oliveira; Maria S Santos; Paula I Moreira
Journal:  Curr Med Chem       Date:  2009-09-01       Impact factor: 4.530

10.  Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin.

Authors:  Juying Han; Fuming Zhang; Jin Xie; Robert J Linhardt; Linda M Hiebert
Journal:  Cardiovasc Diabetol       Date:  2009-08-20       Impact factor: 9.951

View more
  7 in total

1.  Chitosan-cellulose composite for wound dressing material. Part 2. Antimicrobial activity, blood absorption ability, and biocompatibility.

Authors:  April L Harkins; Simon Duri; Luther C Kloth; Chieu D Tran
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2014-01-10       Impact factor: 3.368

2.  A nanocomposite consisting of poly(methyl methacrylate), graphene oxide and Fe3O4 nanoparticles as a sorbent for magnetic solid-phase extraction of aromatic amines.

Authors:  Elham Bashtani; Amirhassan Amiri; Mehdi Baghayeri
Journal:  Mikrochim Acta       Date:  2017-12-05       Impact factor: 5.833

3.  Microfluidic devices with templated regular macroporous structures for HIV viral capture.

Authors:  Krissada Surawathanawises; Kathryn Kundrod; Xuanhong Cheng
Journal:  Analyst       Date:  2016-03-07       Impact factor: 4.616

Review 4.  Polysaccharide-based nanocomposites and their applications.

Authors:  Yingying Zheng; Jonathan Monty; Robert J Linhardt
Journal:  Carbohydr Res       Date:  2014-07-30       Impact factor: 2.104

5.  Adsorption and degradation of doxorubicin from aqueous solution in polypropylene containers.

Authors:  Darren C Wu; Clyde M Ofner
Journal:  AAPS PharmSciTech       Date:  2012-12-11       Impact factor: 3.246

6.  Recyclable synthesis, characterization, and antimicrobial activity of chitosan-based polysaccharide composite materials.

Authors:  Chieu D Tran; Simon Duri; April L Harkins
Journal:  J Biomed Mater Res A       Date:  2013-01-24       Impact factor: 4.396

7.  Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy.

Authors:  Peng He; Shenglin Xu; Zehao Guo; Peng Yuan; Yulei Liu; Yu Chen; Tiantian Zhang; Yukang Que; Yong Hu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.